146 related articles for article (PubMed ID: 30092220)
1. Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro.
Eriksdotter M; Navarro-Oviedo M; Mitra S; Wahlberg L; Linderoth B; Tjernberg LO; Behbahani H
Exp Cell Res; 2018 Oct; 371(1):175-184. PubMed ID: 30092220
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy.
Mitra S; Turchetto S; Van Os W; Wahlberg LU; Linderoth B; Behbahani H; Eriksdotter M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831056
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Eyjolfsdottir H; Eriksdotter M; Linderoth B; Lind G; Juliusson B; Kusk P; Almkvist O; Andreasen N; Blennow K; Ferreira D; Westman E; Nennesmo I; Karami A; Darreh-Shori T; Kadir A; Nordberg A; Sundström E; Wahlund LO; Wall A; Wiberg M; Winblad B; Seiger Å; Wahlberg L; Almqvist P
Alzheimers Res Ther; 2016 Jul; 8(1):30. PubMed ID: 27389402
[TBL] [Abstract][Full Text] [Related]
4. Microglia Impairs Proliferation and Induces Senescence In-Vitro in NGF Releasing Cells Used in Encapsulated Cell Biodelivery for Alzheimer's Disease Therapy.
Mitra S; Gera R; Sundheimer J; Lemee M; Wahlberg LU; Linderoth B; Eriksdotter M; Behbahani H
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012296
[TBL] [Abstract][Full Text] [Related]
5. Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
Crispoltoni L; Stabile AM; Pistilli A; Venturelli M; Cerulli G; Fonte C; Smania N; Schena F; Rende M
J Alzheimers Dis; 2017; 55(3):1005-1017. PubMed ID: 27802234
[TBL] [Abstract][Full Text] [Related]
6. Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor.
Ferreira D; Westman E; Eyjolfsdottir H; Almqvist P; Lind G; Linderoth B; Seiger A; Blennow K; Karami A; Darreh-Shori T; Wiberg M; Simmons A; Wahlund LO; Wahlberg L; Eriksdotter M
J Alzheimers Dis; 2015; 43(3):1059-72. PubMed ID: 25147108
[TBL] [Abstract][Full Text] [Related]
7. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
[TBL] [Abstract][Full Text] [Related]
8. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
15. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.
Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M
J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
Marksteiner J; Pirchl M; Ullrich C; Oberbauer H; Blasko I; Lederer W; Hinterhuber H; Humpel C
Pharmacology; 2008; 82(3):214-20. PubMed ID: 18810245
[TBL] [Abstract][Full Text] [Related]
17. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
18. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.
Sáez ET; Pehar M; Vargas MR; Barbeito L; Maccioni RB
J Neurosci Res; 2006 Oct; 84(5):1098-106. PubMed ID: 16862561
[TBL] [Abstract][Full Text] [Related]
19. Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer.
Fjord-Larsen L; Kusk P; Emerich DF; Thanos C; Torp M; Bintz B; Tornøe J; Johnsen AH; Wahlberg LU
Gene Ther; 2012 Oct; 19(10):1010-7. PubMed ID: 22113314
[TBL] [Abstract][Full Text] [Related]
20. Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.
Castle MJ; Baltanás FC; Kovacs I; Nagahara AH; Barba D; Tuszynski MH
Hum Gene Ther; 2020 Apr; 31(7-8):415-422. PubMed ID: 32126838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
